All included with every plan at no extra cost
Will decisions regarding GLP-1s impact the reputation of your organization
Now, UK regulators have announced that product information for GLP-1s, as well as dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, will include warnings over the disease
Options are out-of-pocket payment for brand-name or compounded medication, or waiting for employer to change plan design during next open enrollment
TeleSlim supports various payment approaches designed to minimize initial cost barriers and align ongoing medication access with patient budgets, including low-monthly starter pricing, discounted multi-month plans, and acceptance of FSA/HSA funds for eligible expenses
This is the result of the peak rate of change in earnings revisions and a reaction function shift at the Fed to focus more on the inflation mandate than growth